InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 19.07
+0.87 (4.78%)
At close: Sep 30, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 11.05 billion as of October 2, 2026. Its market cap has decreased by -38.21% in one year.
Market Cap
11.05B
Enterprise Value
9.74B
Revenue
71.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.07
ChartMarket Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 11.05B, an increase of 25.72%. That is a compound annual growth rate of 5.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 11.05B | -29.84% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jinyu Bio-technology | 12.65B |
| Chengdu Olymvax Biopharmaceuticals | 12.65B |
| Inner Mongolia Furui Medical Science | 12.44B |
| Hualan Biological Vaccine | 11.97B |
| Mabwell (Shanghai) Bioscience | 11.61B |
| Shanghai OPM Biosciences | 11.32B |
| Novoprotein Scientific | 11.15B |
| Tibet Cheezheng Tibetan Medicine | 10.99B |